D
|
| Dalfopristin/quinupristin (Synercid) (Table) |
|
 |
|
| Dalteparin (Fragmin) |
|
 |
| for DVT/PE prophylaxis and treatment |
|
 |
| prescribing information for acute coronary syndrome (Table) |
|
 |
| prescribing information for DVT or PE prophylaxis and treatment (Table) |
|
 |
|
| Danaparoid (Orgaran) (Table) |
|
 |
|
| Dance |
|
 |
| exercise prescription |
|
 |
| for preventing falls (Table) |
|
 |
|
| Daptomycin (Cubicin) (Table) |
|
 |
|
| Daranide (dichlorphenamide) (Table) |
|
 |
|
| Darbepoetin alfa (Aranesp) (Table) |
|
 |
|
| Darifenacin (Enablex) |
|
 |
| drug and metabolic interactions (Table) |
|
 |
| prescribing information for UI (Table) |
|
 |
|
| Daypro (oxaprozin) (Table) |
|
 |
|
| D&C (dilation and curettage) |
|
 |
|
| D-dimer (Figure) |
|
 |
|
| Deafness. See Hearing impairment |
|
 |
|
| Debridement |
|
 |
| for diabetic foot ulcers |
|
 |
| for pressure ulcers |
|
 |
| for skin ulcers |
|
 |
|
| Debrox (carbamide peroxide) |
|
 |
|
| Decaderm (dexamethasone phosphate) (Table) |
|
 |
|
| Decadron |
|
 |
| See also Dexamethasone |
|
 |
| prescribing information for adrenal insufficiency (Table) |
|
 |
| prescribing information for inflammation due to malignant obstruction |
|
 |
|
| Decision making, informed |
|
 |
| Informed Decision Making section |
|
 |
| algorithm for (Figure) |
|
 |
|
| Declomycin (demeclocycline) |
|
 |
|
| Decongestants |
|
 |
| prescribing information for allergic rhinitis or conjunctivitis (Table) |
|
 |
| and sleep problems |
|
 |
|
| Deep heat |
|
 |
|
| Deep-vein thrombosis (DVT) |
|
 |
| anticoagulation for prophylaxis and treatment (Table) |
|
 |
| anticoagulation in absence of active bleeding or severe bleeding risk (Table) |
|
 |
| medications for osteoporosis and (Table) |
|
 |
| prophylaxis |
|
 |
| prophylaxis and treatment |
|
 |
|
| Dehydration |
|
 |
| See also Hydration |
|
 |
| Volume Depletion (Dehydration) section |
|
 |
| and delirium |
|
 |
| at end of life |
|
 |
|
| Delirium |
|
 |
| Delirium chapter |
|
 |
| differential diagnosis |
|
 |
| medication-induced (Table) |
|
 |
|
| Deliver (Table) |
|
 |
|
| Delta-Cortef (prednisolone) (Table) |
|
 |
|
| Deltasone |
|
 |
| See also Prednisone |
|
 |
| prescribing information for adrenal insufficiency (Table) |
|
 |
| prescribing information for asthma and COPD (Table) |
|
 |
|
| Delusional (paranoid) disorder, late-life |
|
 |
|
| Delusions |
|
 |
|
| Demadex |
|
 |
| See also Torsemide |
|
 |
| prescribing information for HTN (Table) |
|
 |
|
| Demecarium (Humorsol) (Table) |
|
 |
|
| Demeclocycline (Declomycin) |
|
 |
|
| Dementia |
|
 |
| Dementia chapter |
|
 |
| daily dose thresholds for antipsychotic medications used to manage behavioral symptoms related to (Table) |
|
 |
| and delirium |
|
 |
| dementia syndrome |
|
 |
| determinants for hospice eligibility (Table) |
|
 |
| differential diagnosis |
|
 |
| distinguishing early Parkinson's disease from other parkinsonian syndrome |
|
 |
| Mini-Cog Assessment Instrument for Dementia |
|
 |
| and osteoporosis |
|
 |
| preoperative risk |
|
 |
|
| Dental procedures: endocarditis prophylaxis for |
|
 |
| for patients with total joint replacements |
|
 |
| procedures warranting prophylaxis |
|
 |
| regimens (Table) |
|
 |
|
| Depacon |
|
 |
| See also Valproic acid |
|
 |
| prescribing information for bipolar disorders (Table) |
|
 |
| prescribing information for seizures (Table) |
|
 |
|
| Depade (naltrexone) |
|
 |
|
| Depakene |
|
 |
| See also Valproic acid |
|
 |
| prescribing information for bipolar disorders (Table) |
|
 |
| prescribing information for seizures (Table) |
|
 |
|
| Depakote (divalproex sodium) |
|
 |
| See also Valproic acid |
|
 |
| prescribing information for agitation (Table) |
|
 |
| prescribing information for bipolar disorders (Table) |
|
 |
| prescribing information for seizures (Table) |
|
 |
|
| Depakote ER (Table) |
|
 |
|
| Depo-Medrol |
|
 |
| See also Methylprednisolone |
|
 |
| prescribing information for adrenal insufficiency (Table) |
|
 |
|
| Deponit |
|
 |
| See also Nitroglycerin |
|
 |
| dosage and formulations (Table) |
|
 |
|
| Depo-Provera |
|
 |
| See also Medroxyprogesterone |
|
 |
| prescribing information for agitation (Table) |
|
 |
|
| Depression |
|
 |
| Depression chapter |
|
 |
| agitation treatment guidelines (Table) |
|
 |
| in Alzheimer's disease |
|
 |
| in bipolar disorder |
|
 |
| in COPD |
|
 |
| differential diagnosis |
|
 |
| at end of life |
|
 |
| and falls |
|
 |
| interventions (Table) |
|
 |
| prevention |
|
 |
| Geriatric Depression Scale (GDS) |
|
 |
| assessment instrument |
|
 |
| in dementia |
|
 |
| medications for (Table) |
|
 |
| screening for (Table) |
|
 |
| and tinnitus |
|
 |
|
| Dermabrasion |
|
 |
|
| Dermatitis, seborrheic |
|
 |
| Seborrheic dermatitis section |
|
 |
| topical antifungals for (Table) |
|
 |
|
| Dermatologic conditions |
|
 |
| Dermatologic Conditions chapter |
|
 |
| conditions common in elderly persons |
|
 |
| resources for |
|
 |
|
| Dermatomes (Figure) |
|
 |
|
| Dermatop (prednicarbate) (Table) |
|
 |
|
| Dermatophytoses (Table) |
|
 |
|
| Desipramine (Norpramin) |
|
 |
| drug and metabolic interactions (Table) |
|
 |
| for pain relief |
|
 |
| prescribing information for depression (Table) |
|
 |
| prescribing information for painful neuropathy |
|
 |
|
| Desloratadine (Clarinex) (Table) |
|
 |
|
| Desonide (DesOwen, Tridesilon) (Table) |
|
 |
|
| DesOwen (desonide) (Table) |
|
 |
|
| Desoximetasone (Topicort) |
|
 |
| prescribing information for dermatologic conditions (higher potency) (Table) |
|
 |
| prescribing information for dermatologic conditions (mid-potency) (Table) |
|
 |
|
| Desyrel |
|
 |
| See also Trazodone |
|
 |
| prescribing information for agitation (Table) |
|
 |
| prescribing information for sleep disorders (Table) |
|
 |
|
| Detrol (tolterodine) (Table) |
|
 |
|
| Detrol LA (tolterodine) (Table) |
|
 |
|
| Detrusor contractility, impaired |
|
 |
|
| Detrusor hyperactivity with impaired contractility (DHIC) |
|
 |
| classification of |
|
 |
| evaluation of |
|
 |
| management of |
|
 |
|
| Detrusor instability |
|
 |
|
| Detrusor muscle-relaxing drugs |
|
 |
|
| Dexacort |
|
 |
| See also Dexamethasone |
|
 |
| prescribing information for allergic rhinitis or conjunctivitis (Table) |
|
 |
| prescribing information for asthma and COPD (Table) |
|
 |
|
| Dexamethasone (Decadron, Dexacort, Dexone, Hexadrol) |
|
 |
| prescribing information for adrenal insufficiency (Table) |
|
 |
| prescribing information for allergic rhinitis or conjunctivitis (Table) |
|
 |
| prescribing information for anorexia, cachexia, dehydration |
|
 |
| prescribing information for asthma and COPD (Table) |
|
 |
| prescribing information for inflammation due to malignant obstruction |
|
 |
|
| Dexamethasone phosphate (Decaderm) (Table) |
|
 |
|
| Dexedrine (dextroamphetamine) |
|
 |
|
| Dexone |
|
 |
| See also Dexamethasone |
|
 |
| prescribing information for adrenal insufficiency (Table) |
|
 |
|
| Dextroamphetamine (Dexedrine) |
|
 |
|
| Dextromethorphan (Robitussin DM) |
|
 |
| for cough (Table) |
|
 |
| drug and metabolic interactions (Table) |
|
 |
| prescribing information for cough (Table) |
|
 |
|
| Dextrose solution |
|
 |
| for hyperkalemia |
|
 |
| for hyperkalemia inpatient management |
|
 |
| for parenteral nutrition (Table) |
|
 |
|
| DH Pressure Relief Walker |
|
 |
|
| DHIC (detrusor hyperactivity with impaired contractility) |
|
 |
| classification of |
|
 |
| evaluation of |
|
 |
| management of |
|
 |
|
| Diaβeta (glyburide) (Table) |
|
 |
|
| Diabetes control |
|
 |
| in chronic kidney failure |
|
 |
| post MI |
|
 |
|
| Diabetes insipidus |
|
 |
|
| Diabetes mellitus |
|
 |
| Diabetes Mellitus section |
|
 |
| antihypertensive therapy and (Table) |
|
 |
| eye examinations |
|
 |
| insulin preparations (Table) |
|
 |
| lactose-free oral and enteral formulations (Table) |
|
 |
| non-insulin agents for (Table) |
|
 |
| and PAD |
|
 |
| resources for |
|
 |
| screening (Table) |
|
 |
|
| Diabetic peripheral neuropathy |
|
 |
| pain relief (Table) |
|
 |
| treatment of |
|
 |
|
| Diabetic retinopathy |
|
 |
| causes |
|
 |
| nonpharmacologic treatment |
|
 |
| pharmacologic treatment |
|
 |
|
| Diabetic ulcers |
|
 |
| Diabetic Foot Ulcers section |
|
 |
| wound characteristics (Table) |
|
 |
|
| Dialysis |
|
 |
| for acute kidney failure |
|
 |
| for chronic kidney failure |
|
 |
| hemodialysis |
|
 |
| for hyperkalemia |
|
 |
| peritoneal dialysis |
|
 |
|
| Diamox (acetazolamide) (Table) |
|
 |
|
| Diarrhea |
|
 |
| Diarrhea section |
|
 |
| antibiotic-associated |
|
 |
| antidiarrheals |
|
 |
| at end of life |
|
 |
| with enteral feedings |
|
 |
| and hyponatremia |
|
 |
|
| Diastolic dysfunction |
|
 |
| drug therapy for |
|
 |
| evaluation and assessment |
|
 |
|
| Diazepam (Valium) |
|
 |
| for anxiety |
|
 |
| drug and metabolic interactions (Table) |
|
 |
|
| Dichlorphenamide (Daranide) (Table) |
|
 |
|
| Diclofenac (Cataflam, Voltaren, Voltaren-XR) |
|
 |
| drug and metabolic interactions (Table) |
|
 |
| with misoprostol (Arthrotec) (Table) |
|
 |
| prescribing information for arthritis (Table) |
|
 |
|
| Dicloxacillin (Dycill, Pathocil) |
|
 |
| prescribing information for infectious diseases (Table) |
|
 |
| warfarin interactions |
|
 |
|
| Dicyclomine |
|
 |
|
| Dietary modification |
|
 |
| cholesterol-lowering diet |
|
 |
| for constipation |
|
 |
| for fecal incontinence |
|
 |
| high-fiber diet |
|
 |
| for HTN |
|
 |
| for IBS |
|
 |
| low-fat diet |
|
 |
| for orthostatic (postural) hypotension |
|
 |
| for stroke prevention |
|
 |
|
| Diflorasone diacetate (Florone, Maxiflor, Psorcon) |
|
 |
| prescribing information for dermatologic conditions (high potency) (Table) |
|
 |
| prescribing information for dermatologic conditions (higher potency) (Table) |
|
 |
| prescribing information for dermatologic conditions (super potency) (Table) |
|
 |
|
| Diflucan |
|
 |
| See also Fluconazole |
|
 |
| prescribing information for infectious diseases (Table) |
|
 |
| prescribing information for onychomycosis |
|
 |
|
| Diflunisal (Dolobid) (Table) |
|
 |
|
| Digital rectal examination (Table) |
|
 |
|
| Digital stimulation |
|
 |
|
| Digoxin (Lanoxin, Lanoxicaps) |
|
 |
| for AF |
|
 |
| drug interactions, dangerous |
|
 |
| drug interactions, general |
|
 |
| ocular adverse events |
|
 |
| prescribing information for HF |
|
 |
|
| DiGugleilmo's syndrome |
|
 |
|
| Dihydropyridines |
|
 |
| and coexisting conditions (Table) |
|
 |
| drug and metabolic interactions (Table) |
|
 |
| prescribing information for HTN (Table) |
|
 |
|
| Dilacor XR (diltiazem) (Table) |
|
 |
|
| Dilantin |
|
 |
| See also Phenytoin |
|
 |
| prescribing information for epilepsy (Table) |
|
 |
|
| Dilation and curettage (D&C) |
|
 |
|
| Dilatrate SR (isosorbide dinitrate) (Table) |
|
 |
|
| Dilaudid |
|
 |
| See also Hydromorphone |
|
 |
| prescribing information for pain (Table) |
|
 |
|
| Diltiazem |
|
 |
| for AF |
|
 |
| digoxin interactions |
|
 |
| drug and metabolic interactions (Table) |
|
 |
| enteral nutrition interactions |
|
 |
|
| Diltiazem SR (Cardizem CD, Cardizem SR, Dilacor XR, Tiazac) (Table) |
|
 |
|
| Diovan |
|
 |
| See also Valsartan |
|
 |
| prescribing information for HTN (Table) |
|
 |
|
| Diovan HCT (valsartan with HCTZ) (Table) |
|
 |
|
| Diphenhydramine (Benadryl) |
|
 |
| daily dose thresholds (Table) |
|
 |
| and dementia |
|
 |
| for painful mucositis |
|
 |
| prescribing information for allergic rhinitis or conjunctivitis (Table) |
|
 |
|
| Diphenhydrinate (Dramamine) (Table) |
|
 |
|
| Diphenoxylate with atropine (Lomotil) (Table) |
|
 |
|
| Dipivefrin (AKPro, Propine) (Table) |
|
 |
|
| Diprolene |
|
 |
| See also Betamethasone dipropionate |
|
 |
| prescribing information for dermatologic conditions (Table) |
|
 |
|
| Diprolene AF |
|
 |
| See also Betamethasone dipropionate |
|
 |
| prescribing information for dermatologic conditions (Table) |
|
|